InvestorsHub Logo
Followers 97
Posts 4810
Boards Moderated 0
Alias Born 02/07/2021

Re: jimmy667 post# 502160

Sunday, 08/07/2022 10:56:51 AM

Sunday, August 07, 2022 10:56:51 AM

Post# of 699495
An investment of $10 billion would be equivalent to $40 a share for common. That would allow the firm to initiate additional trials for DCVax-L so it can treat other cancer indications.

Given the patent cliff which many BPs are facing for their checkpoint inhibitors, I believe we will see more combination trials funded as well. Since there's an urgent need here to protect market share that's being threatened very soon I believe the partnership will be at this level of scale. BP partners know spending money must happen to create long term revenue so I believe the partnership will be:

"Go Big Or Go Home!"

Being first to capture market share matters as that helps establish a durable competitive advantage. So BP partner will not dither around with a few hundred million as that's not enough for them to ensure we make it impossible for competitors to arise in the same market. A single trial costs half a billion. Thus the JV will be billions and billions. This would be my strategy if I was in a position to partner with Northwest Biotherapeutics.

"Big opportunities come infrequently. When it's raining gold, reach for a bucket, not a thimble - Warren Buffett."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News